Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Using viruses to targetedly fight advanced cancer

Photo: ViraTherapeutics © Photo: ViraTherapeutics

The new type of treatment should already be available in this decade for the benefit of cancer patients for whom current therapies have failed. The immune vaccination developed in Tyrol to destroy tumors is considered to be a “global breakthrough, in light of the fact that, according to all results up until now in cell cultures and mouse models, it remains a highly specific effective vaccination when used in multiple applications, and does not harm healthy cells. This distinguishes our oncolytic virus from more than 20 others which are currently being researched as potentially new forms of cancer treatment”, says Dorothee Holm-von Laer, Managing Director of  ViraTherapeutics GmbH and Director of the Division of Virology at the Medical University of Innsbruck.

Innovation from Tyrol – a health-promoting virus with a cloak of invisibility

The virus developed in highly precise molecular-biological and genetic work in Innsbruck is called “VSV-GP”. It is a combination of two viruses which are harmless to people. The protein cover of the vesicular stomatitis virus (VSV) was replaced by the glycoprotein of the lymphocytic choriomeningitis virus. “This covering acts like a cloak of invisibility. It partially protects VSV-GP from recognition by the body’s immune system. Even if used repeatedly, this oncolytic virus can destroy cancer cells”, explains the biochemist Lisa Egerer, who is head of the new laboratory of ViraTherapeutics GmbH. Virotherapy is an up and coming field of research. Using viruses to treat cancer has only become a focus of research in recent years.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us @ Plast/Ipack Ima

    29. - 30.05.2018, Milano, Italia

  • Austrian Economic Mission in Baltic States

    30.05.2018, Vilnius, Lithuania

Austria Map

Find the perfect location for your company

Austria stands out due to its long-term reliable and stable conditions. These
features are particularly important for a research-based company such as
Boehringer Ingelheim. Furthermore, Vienna is a city with a good research
infrastructure and a high quality of life, and is thus also an interesting place
for highly qualified employees from Austria and abroad.

Boehringer Ingelheim

Logo
More testimonials

news from the business location Austria

In May Austria is THE startup hotspot

In their role as speakers, Apple co-founder Steve Wozniak, Angie Jones of Twitter and Microsoft AI expert Joseph Sirosh inspired an audience of 8,000 people attending the WeAreDevelopers Conference in Vienna in the middle of May.

Headquarters Cluster: New Impetus from Digitalization

Some 380 regional corporate headquarters are based in Austria. This is complemented by hundreds of Austrian companies which have emerged as global headquarters within the context of their internationalization. As a result, the Vienna metropolitan area ranks among the leading headquarters locations in Europe.

More news All blog posts